Dermalux is the UK market leader in light-emitting diode (LED) phototherapy.
The award-winning company specialises in the development of innovative energy-based devices for the medical, aesthetic and cosmetic markets. Using LEDs to stimulate cellular activity and promote skin rejuvenation, the Dermalux product line delivers non-invasive treatment options to address various skin conditions.
When Omni was introduced to Dermalux, we quickly realised that the company was well placed to capitalise on the emergence of LED phototherapy within the broader medical, aesthetic and cosmetic markets. Market growth has accelerated due to the increasing focus on skin care, incidence of skin disorders and preference for non-invasive and cost-effective treatments with minimal healing time. Recognising the company’s existing dominance in the UK market, we identified the importance of international expansion and maintaining a robust R&D pipeline to help the company achieving its growth targets.Â
Omni’s investment enables Dermalux to:
- Recruit a new CEO, CFO and CMO
- Update and broaden the Dermalux product line
- Undertake a major rebrand to ensure product positioning reflects the premium best-in-market Dermalux product line
- Grow international market share
